United States · Funded startup

Who invested in Rose Diagnostics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 2 months ago

Funding summaryUpdated 15 Nov 2026

$2.2Mraised across 1 round since 2026, from 1 source

Latest round
Round, $2.2MSept 2026
Investors
0
See who backed them

The rounds

  1. Sept 2026
    Round$2.2M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $2.2M sold, first sale Sept 2026

Funding filed with regulators

Rose Diagnostics filed 4 raises, $5.7M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Sept 2026$2.2M18 investorsof $3.0M offeredSEC Form D
  2. May 2025$2.3M18 investorsof $3.0M offeredSEC Form D
  3. Mar 2025$124Kotherof $1.2M offeredCrowdfunding
  4. Jun 2024$1.0M13 investorsequitySEC Form D

Founders and team

From Rose Diagnostics's own website: 2 founders.

Andrew MorrisCEO, Founder
Adolfo VelazquezCTO, Founder

Quick answers about Rose Diagnostics

How much has Rose Diagnostics raised?

Rose Diagnostics has raised $2.2M across 1 round since 2026.

When did Rose Diagnostics last raise?

Rose Diagnostics's most recent round, $2.2M, was in Sept 2026.

What was Rose Diagnostics's biggest round?

Its most recent round, $2.2M in Sept 2026, is also its largest on record.

Where is Rose Diagnostics based?

Rose Diagnostics is based in the United States.

Companies like Rose Diagnostics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.